Print

Active Biotech's Capital Market Meeting with Teva Pharmaceutical Industries in Stockholm on October 19

2004-10-18

To listen to the meeting and to view the presentation afterwards, please call +44 20 8288 4459 or +1 334 323 6222 (US), access code 430602, or visit www.activebiotech.com.
Active Biotech AB is a biotechnology company focusing on research in and development of pharmaceuticals. Active Biotech has a strong R&D portfolio and pipeline products with focus primarily on autoimmune/inflammatory diseases and cancer. Most advanced projects include orally administered small molecules with unique immunomodulatory properties that can be used to treat autoimmune and inflammatory diseases (SAIK-MS), as well as a novel concept for use in cancer immunotherapy (TTS).

Active Biotech AB
P.O. Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 20 50

pdf



Back